Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)
Condition(s):Triple Negative Breast Cancer (TNBC)Last Updated:March 5, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Triple Negative Breast Cancer (TNBC)Last Updated:March 5, 2024Recruiting
Condition(s):Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Acute Myeloid LeukemiaLast Updated:October 31, 2022Withdrawn
Condition(s):Peripheral T Cell LymphomaLast Updated:October 17, 2022Withdrawn
Condition(s):Locally Advanced Breast Cancer; Metastatic Breast CancerLast Updated:May 17, 2023Completed
Condition(s):SARS-CoV-2 InfectionLast Updated:April 21, 2022Completed
Condition(s):Solid Tumor; Extensive-stage Small-cell Lung Cancer; Locally Advanced Breast Cancer; Metastatic Breast Cancer; Platinum-sensitive Ovarian Cancer; Platinum-Sensitive Fallopian Tube Carcinoma; Platinum-Sensitive Peritoneal CancerLast Updated:March 6, 2024Active, not recruiting
Condition(s):Healthy VolunteersLast Updated:August 18, 2021Completed
Condition(s):Leukemia, Lymphocytic, Chronic, B-CellLast Updated:July 23, 2021Completed
Condition(s):T Cell LymphomaLast Updated:October 28, 2022Completed
Condition(s):Hematological MalignanciesLast Updated:May 17, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.